Abstract: A buoyant apparatus that is capable of floating on liquid surfaces, such as bodies of water filled with waste byproducts. The buoyant apparatus supports a plurality of atomizers via rotatable and flexible arms that can achieve 180° adjustments with the respect to a longitudinal axis of the buoyant apparatus, such that the arms can be parallel to a surface of the body of water in both an extended orientation (with the atomizers deployed over the water surface) and a retracted orientation (with the atomizers stored within the surface area of the platform). In addition, the arms can achieve 360° rotational adjustments about the attachment point of the arms to the platform. The atomizers and arms are powered by low voltage direct current (DC) motors that can utilize solar power via photovoltaic cells such that the apparatus can be employed in remote locations without the need for a centralized power grid.

Abstract: A buoyant apparatus that is capable of floating on liquid surfaces, such as bodies of water filled with waste byproducts. The buoyant apparatus supports a plurality of atomizers via rotatable and flexible arms that can achieve 180° adjustments with the respect to a longitudinal axis of the buoyant apparatus, such that the arms can be parallel to a surface of the body of water in both an extended orientation (with the atomizers deployed over the water surface) and a retracted orientation (with the atomizers stored within the surface area of the platform). In addition, the arms can achieve 360° rotational adjustments about the attachment point of the arms to the platform. The atomizers and arms are powered by low voltage direct current (DC) motors that can utilize solar power via photovoltaic cells such that the apparatus can be employed in remote locations without the need for a centralized power grid.

Abstract: A method for determining predisposition of a subject to developing renal dysfunction (AKI), and to a kit for use in making such a determination is provided. Suitably at least one marker selected from Midkine (MK) or H-FABP present in a blood or urine sample is used in the method.

Abstract: A buoyant apparatus that is capable of floating on liquid surfaces, such as bodies of water filled with waste byproducts. The buoyant apparatus supports a plurality of atomizers via rotatable and flexible arms that can achieve 180° adjustments with the respect to a longitudinal axis of the buoyant apparatus, such that the arms can be parallel to a surface of the body of water in both an extended orientation (with the atomizers deployed over the water surface) and a retracted orientation (with the atomizers stored within the surface area of the platform). In addition, the arms can achieve 360° rotational adjustments about the attachment point of the arms to the platform. The atomizers and arms are powered by low voltage direct current (DC) motors that can utilize solar power via photovoltaic cells such that the apparatus can be employed in remote locations without the need for a centralized power grid.

Abstract: The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.

Abstract: The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.

Abstract: An atomizer for use in waste water evaporation includes a motor having a rotor shaft, at least one conduit for receiving the waste water, a housing supporting the motor and the at least one conduit, and a hub having a plurality of holes for distributing waste water in the form of water droplets. The motor is a variable speed motor and is cooled by waste water flowing through the at least one conduit. The hub is connected to the rotor shaft and spins at a variable speed with the rotor shaft. The atomizer may be used in a waste water evaporation system that further includes an anemometer and a control system. The control system receives a wind speed input from the anemometer and provides a signal to the variable speed motor to adjust the speed of the variable speed motor and hub, thereby adjusting the water droplet size in response to varying wind conditions.

Abstract: The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.

Abstract: An atomizer for use in waste water evaporation includes a motor having a rotor shaft, at least one conduit for receiving the waste water, a housing supporting the motor and the at least one conduit, and a hub having a plurality of holes for distributing waste water in the form of water droplets. The motor is a variable speed motor and is cooled by waste water flowing through the at least one conduit. The hub is connected to the rotor shaft and spins at a variable speed with the rotor shaft. The atomizer may be used in a waste water evaporation system that further includes an anemometer and a control system. The control system receives a wind speed input from the anemometer and provides a signal to the variable speed motor to adjust the speed of the variable speed motor and hub, thereby adjusting the water droplet size in response to varying wind conditions.

Abstract: An atomizer for use in waste water evaporation includes a motor having a rotor shaft, at least one conduit for receiving the waste water, a housing supporting the motor and the at least one conduit, and a hub having a plurality of holes for distributing waste water in the form of water droplets. The motor is a variable speed motor and is cooled by waste water flowing through the at least one conduit. The hub is connected to the rotor shaft and spins at a variable speed with the rotor shaft. The atomizer may be used in a waste water evaporation system that further includes an anemometer and a control system. The control system receives a wind speed input from the anemometer and provides a signal to the variable speed motor to adjust the speed of the variable speed motor and hub, thereby adjusting the water droplet size in response to varying wind conditions.

Abstract: The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.

Abstract: The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and their use to prevent, mitigate or treat a) damage induced by ionizing radiation, b) inflammation or c) cancer.

Abstract: An atomizer for use in waste water evaporation includes a motor having a rotor shaft, at least one conduit for receiving the waste water, a housing supporting the motor and the at least one conduit, and a hub having a plurality of holes for distributing waste water in the form of water droplets. The motor is a variable speed motor and is cooled by waste water flowing through the at least one conduit. The hub is connected to the rotor shaft and spins at a variable speed with the rotor shaft. The atomizer may be used in a waste water evaporation system that further includes an anemometer and a control system. The control system receives a wind speed input from the anemometer and provides a signal to the variable speed motor to adjust the speed of the variable speed motor and hub, thereby adjusting the water droplet size in response to varying wind conditions.

Abstract: The instant invention presents a system and method for performing local searches across one or more events created by one or more users. The system of the present invention comprises an event data structure comprising one or more user defined events, each event associated with a zip code. A zip list processor is provided to receive a zip code and a distance value, e.g., from user defined input, which are used to calculate a zip list comprising all zip codes geographically located with the distance value from the zip code. An event list generator to receives the zip list and queries the event data structure to retrieve events associated with zip codes contained in the zip list.

Abstract: The instant invention presents a system and method for performing local searches across one or more events created by one or more users. The system of the present invention comprises an event data structure comprising one or more user defined events, each event associated with a zip code. A zip list processor is provided to receive a zip code and a distance value, e.g., from user defined input, which are used to calculate a zip list comprising all zip codes geographically located with the distance value from the zip code. An event list generator to receives the zip list and queries the event data structure to retrieve events associated with zip codes contained in the zip list.

Abstract: The instant invention presents a system and method for performing local searches across one or more events created by one or more users. The system of the present invention comprises an event data structure comprising one or more user defined events, each event associated with a zip code. A zip list processor is provided to receive a zip code and a distance value, e.g., from user defined input, which are used to calculate a zip list comprising all zip codes geographically located with the distance value from the zip code. An event list generator to receives the zip list and queries the event data structure to retrieve events associated with zip codes contained in the zip list.

Abstract: Therapeutically active thiazole derivatives of formula (I) wherein R1-R2, X and X? as are defined in the specification, processes for the preparation thereof, the use thereof in therapy, particularly in the treatment or prophylaxis of disorders characterised by overexpression of transforming growth factor • (TGF-•), and pharmaceutical compositions for use in such therapy.

Abstract: The present invention provides compounds of the formula X—R1-D-[Dpr, Orn or Lys](A)-R2(Z)-D-[Dpr, Orn or Lys](B)—R3(Y)—NR4R5; or R1(X)-D-[Dpr, Orn or Lys](A)-R2(Z)-D-[Dpr, Orn or Lys](B)—R3(Y)—NR4R5, in which X is a hard acid cation chelator, a soft acid cation chelator or Ac—, R1, R2 and R3 are independently selected from a covalent bond or one or more D-amino acids that can be the same or different, Y is a hard acid cation chelator, a soft acid cation chelator or absent, Z is a hard acid cation chelator, a soft acid cation chelator or absent, and A and B are haptens or hard acid cation chelators and can be the same or different, and R4 and R5 are independently selected from the group consisting of hard acid cation chelators, soft acid cation chelators, enzymes, therapeutic agents, diagnostic agents and H. The present invention also provides methods of using these compounds and kits containing the compounds.

Abstract: The present invention concerns methods and compositions for making and using bioactive assemblies of defined compositions, which may have multiple functionalities and/or binding specificities. In particular embodiments, the bioactive assembly is formed using dock-and-lock (DNL) methodology, which takes advantage of the specific binding interaction between dimerization and docking domains (DDD) and anchoring domains (AD) to form the assembly. In various embodiments, one or more effectors may be attached to a DDD or AD sequence. Complementary AD or DDD sequences may be attached to an adaptor module that forms the core of the bioactive assembly, allowing formation of the assembly through the specific DDD/AD binding interactions. Such assemblies may be attached to a wide variety of effector moieties for treatment, detection and/or diagnosis of a disease, pathogen infection or other medical or veterinary condition.

Abstract: F-18 radiolabeled peptides are prepared by reacting a peptide comprising a hydroxylamine, a thiosemicarbazide, a hydrazine or a free amine group with 4-[18F]Fluorobenzaledyde. Specific, non-limiting examples of F-18 radiolabeled peptides are described herein. The labeled peptides are useful, for example, in clinical positron emission tomography.